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Summary
We report that the Bjornstad syndrome gene maps to
chromosome 2q34-36. The clinical association of sen-
sorineural hearing loss with pili torti (broken, twisted
hairs) was described 130 years ago by Bjornstad; sub-
sequently, several small families have been studied. We
evaluated a large kindred with Bjornstad syndrome in
which eight members inherited pili torti and prelingual
sensorineural hearing loss as autosomal recessive traits.
A genomewide search using polymorphic loci demon-
strated linkage between the disease gene segregating in
this kindred and D2S434 (maximum two-point LOD
score  4.98 at v  0). Haplotype analysis of recom-
bination events located the disease gene in a 3-cM region
between loci D2S1371 and D2S163. We speculate that
intermediate filament and intermediate filament-associ-
ated proteins are good candidate genes for causing
Bjornstad syndrome.
Introduction
The incidence of severe prelingual hearing impairment
is ∼1/1,000 births (Morton 1991). In developed coun-
tries, ∼60% of these cases are thought to have a genetic
origin (Marazita et al. 1993), with ∼30% occurring as
part of a syndrome (Reardon 1992). The genetics of
hearing loss is complex. Mutations at 140 loci can cause
nonsyndromic deafness (autosomal and sex linked). In
addition, there are 1300 syndromes associated with
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hearing loss, and the disease genes responsible for a few
of them have been identified (Gorlin, Toriello, and Co-
hen 1995; Van Camp and Smith 1998). Mutations in
myosin 7A, Pendrin, PAX3, and COL 4A have been
shown to cause Usher 1B, Pendred, Waardenburg, and
Alport syndromes, respectively (Petit 1996). However,
the mutated genes responsible for many syndromes as-
sociated with deafness have yet to be identified.
In 1965, Bjornstad described a new syndrome char-
acterized by the presence of pili torti (brittle, broken
hair) and congenital sensorineural hearing loss (desig-
nated “Bjornstad syndrome”; OMIM 262000). In the
initial description of several families, five patients dem-
onstrated both pili torti and sensorineural hearing loss
(Bjornstad 1965). The terms “pili torti” and “twisted
hair” had already been applied 33 years earlier (Ronch-
ese 1932) to describe a rare hair abnormality in which
the hair shafts are flattened at irregular intervals and
twisted through 180 about the axes, causing them to
break spontaneously (Petit et al. 1993). Pili torti may be
congenital or acquired (the latter form secondary to
patchy alopecia from a variety of causes). The congenital
form may be isolated and determined by an autosomal
dominant gene or associated with various rare syn-
dromes, including Menkes syndrome, ectodermal dys-
plasia, neurological defects, and metabolic disturbances
(Kurwa and Abdel-Aziz 1973; Birnbaum and Baden
1987). Pili torti, which may involve all or part of the
scalp, is usually recognized during the 2d year of life
(Robinson and Johnston 1967). Typically, hair trimming
is not required, because it fractures at a short length
(Petit et al. 1993).
Twenty-one cases of Bjornstad syndrome have been
described (Bjornstad 1965; Reed et al. 1967; Robinson
and Johnston 1967; Munro 1971; Cremers and Geerts
1979; Voigtlander 1979; Scott et al. 1983; Petit et al.
1993). Ten of these cases were familial (Reed et al. 1967;
Cremers and Geerts 1979; Voigtlander 1979; Petit et al.
1993), with the largest families composed of three af-
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Figure 1 Pedigree of the kindred with Bjornstad syndrome. Open symbols  unaffected; solid symbols  affected; stippled  unknown
clinical status; squares  men; circles  women; diamond  siblings of generation III not studied; double lines indicate consanguinity (in both
cases, the marriages occurred between second cousins); symbols representing deceased individuals are slashed.
fected members (Reed et al. 1967; Petit et al. 1993).
Although there are two reports of pili torti and deafness
being inherited in a pattern consistent with an autosomal
dominant mode of transmission (Cremers and Geerts
1979; Petit et al. 1993), the pattern seen in most families
suggests an autosomal recessive mode of inheritance
(Bjornstad 1965; Reed et al. 1967; Voigtlander 1979).
Despite detailed clinical descriptions of this disorder,
the molecular cause of Bjornstad syndrome remains un-
known. To elucidate the underlying defect and inheri-
tance of this syndrome, we performed a genetic linkage
study in a large family with eight affected members. Our
analysis demonstrated that the locus responsible for
Bjornstad syndrome maps to chromosome 2q34-36.
Subjects and Methods
Patients
This study was reviewed by and conducted in accor-
dance with the policy of the Institutional Review Board
of the Massachusetts Eye and Ear Infirmary. All family
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Figure 2 Photograph of an affected member. A, Characteristic short, frizzled hairs and the use of a hearing aid. B, Posterior view of the
patient, showing sparse and short hair.
members of legal age signed informed consent forms to
participate in this study. Eighteen family members from
three generations of a Mexican family (mixed Spanish
and native Indian heritage) were evaluated (by J.F.L.N.
and M.A.M.F.) with a questionnaire (to assess other
known causes and risk factors for hearing loss), a limited
physical examination including auscultation and fun-
doscopy, and a comprehensive otolaryngologic evalua-
tion (exam, audiogram, and vestibular testing). Pure-
tone audiometry was performed (by R.M.C.) with air
conduction at 250, 500, 1,000, 2,000, 4,000, 6,000, and
8,000 Hz and with bone conduction at 500, 1,000,
2,000, and 4,000 Hz. Hair and blood samples were ob-
tained for microscopy and genetic analyses, respectively,
and were transported into the United States with knowl-
edge of the Mexican Health Ministry. Family members
with prelingual hearing loss and pili torti were diagnosed
with Bjornstad syndrome.
Genetic Analyses
Karyotype analyses were performed on samples from
two affected individuals (III-1 and IV-1, fig. 1) as de-
scribed by Hook (1977). Genomic DNA was extracted
from whole blood samples by standard techniques (Tan-
igawa et al. 1990), and diluted to 50 ng/liter for am-
plification by PCR with fluorescein-labeled primers from
the Cooperative Human Linkage Center Human Screen-
ing Set/Weber Version 8 (Research Genetics). The vol-
umes of final reactions were 5 ml and contained 10 ng
of template genomic DNA, 0.25 U of Taq polymerase,
2 pmol of forward and reverse primers, 0.2 mM deox-
ynucleotides, and 2.5 mMMgCl2; 1# Cetus PCR buffer
was used. Samples were denatured at 95C for 10 min,
followed by PCR reactions (10 cycles: 94C for 30 s,
55C for 30 s, and 72C for 1 min; 20 cycles: 89C for
30 s, 55C for 30 s, and 72C for 1 min). The pooled
products were supplemented with Tamra red–labeled in-
ternal-size standards and were electrophoresed on an
Applied Biosystems model 377 Sequencer and analyzed
by Genescan version 2.1 peak calling software and by
the Applied Biosystems Genotyper version 2.0 program.
Additional polymorphic markers from Research Ge-
netics were tested to confirm the linkage, narrow the
disease interval, and construct a haplotype. The PCRs
were performed with 3 ml (150 ng) of DNA in a 7-ml
reaction mixture containing 1 ml 10# Cetus buffer (100
nM Tris-HCL, pH 8.3, 500 mM KCl, and 25 nM
MgCl2), 1 ml of nucleotide mix (1.25 mM each of dATP,
dCTP, dGTP, and dTTP); 2 pmol of forward
(g32P–labeled) and 2 pmol of reverse primers; and 1 U
(0.2 l) Taq polymerase. Thirty-two cycles of amplifica-
tion were completed at 94C for 20 s, 55–58C for 30
s, and 72C for 30–45 s. Reaction products were sep-
arated on 6% denaturing polyacrylamide gels (7.7 M
urea) and analyzed by autoradiography.
Linkage Analyses
Two-point LOD scores were performed between the
disease gene and each marker, using theMLINK (version
5.1) program, assuming allele frequencies derived from
25 unrelated individuals. The Bjornstad syndrome gene
mutation (both pili torti and sensorineural hearing loss)
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Figure 3 Scanning electron micrograph of hairs. A, Hair twisted
180 on its own axis (X200). B, Broken hair at a twist (X500).
Table 1
Linkage between the Disease Gene and Chromosome 2
Loci
LOD SCORE AT v 
LOCUS 0 .01 .05 .10 .20 .30
D2S2382  .79 .33 .58 .43 .04
D2S164  2.88 3.23 3.07 2.38 1.49
D2S2210  2.85 3.18 2.99 2.26 1.32
D2S1371  1.71 2.13 2.07 1.61 .96
D2S173 2.49 2.44 2.25 2.01 1.50 .95
D2S434 4.98 4.88 4.49 3.99 2.92 1.77
D2S433 4.04 3.97 3.65 3.25 2.39 1.48
D2S2179  1.44 1.88 1.84 1.41 .84
D2S163  .38 .78 1.07 1.01 .66
D2S120  1.44 -.20 .20 .40 .33
D2S424  .38 .78 1.07 1.01 .67
D2S2372  1.92 2.34 2.27 1.80 1.16
D2S313  1.3 .48 .97 1.02 .64
D2S360  .46 .72 1.04 1.05 .76
D2S351  1.12 .67 1.18 1.24 .87
D2S1363  1.29 .48 .96 .99 .59
was assumed to be a fully penetrant under a recessive
model. The Bjornstad syndrome gene frequency was es-
timated at .001 for LOD score calculations. Equal re-
combination frequencies between males and females
were assumed.
Scanning Electron Microscopy
Hair samples were mounted on conductive carbon
tape, sputter coated with gold/paladium, and viewed
with an Amray 1000A scanning electron microscope.
Results
Clinical Evaluations
Eight individuals in one large kindred (designated
“family BS-1”) were diagnosed as affected with Bjorn-
stad syndrome on the basis of hair and hearing analysis.
All affected individuals had nonprogressive prelingual
hearing loss and used hearing aids. Two used sign lan-
guage for communication (IV-1 and IV-4) and had au-
diometric profiles of profound sensorineural deafness.
The audiological examination in the remaining six dem-
onstrated a pattern consistent with mild to moderate
hearing impairment in lower to middle frequencies and
moderate to severe impairment in higher frequencies.
These six individuals had relatively normal language and
speech.
All eight affected individuals had hair abnormalities
involving the entire scalp that were usually recognized
by the parents during the 2d year of life. Hair was sparse,
coarse, dry, lusterless, and fragile (fig. 2). Affected in-
dividuals had never required haircuts. A scanning elec-
tron micrograph of a scalp hair sample from one affected
individual is shown in figure 3. Eyebrows and eyelashes
and axillary, pubic, and body hair were normal.
The hormonal status of affected individuals appeared
normal. All affected women denied menstrual abnor-
malities; two girls (ages !14 years) had secondary sexual
characteristics that were normal for age. One affected
male (individual III-1) is married and has two unaffected
children (data not shown).
There was no history of pili torti and congenital sen-
sorineural hearing loss in other surviving or deceased
family members. Remarkable findings in other family
members included one child with isolated and profound
sensorineural hearing loss (individual IV-5, fig. 1) ne-
cessitating sign language; one adult (individual II-1) had
vitiligo of both hands. Histories and physical exami-
nations were otherwise unremarkable in both affected
and unaffected family members. Neither tinnitus nor diz-
ziness was reported by any family member. There were
no nail or teeth malformations and no individual had a
white forelock. No nystagmus, pinna malformations, or
seventh cranial nerve dysfunction was observed.
Genetic Studies
Pedigree analyses were consistent with autosomal re-
cessive transmission of Bjornstad syndrome in family BS-
1 (fig. 1). Karyotype analyses were performed on samples
from individuals III-1 and IV-1 and revealed no abnor-
malities. Genetic studies were performedwithDNA sam-
ples from 18 individuals. Because Bjornstad syndrome
Lubianca Neto et al.: Mapping the Bjornstad Syndrome Gene 1111
Figure 4 Schematic representation of the genotypes of three individuals who were discordant with clinical status in the 5-cM interval
between D2S2382 and D2S424. Pedigree identification numbers (ID) and clinical status (clin. stat.: U  unaffected; A  affected) are shown.
Black filled bars represent nonconcordance between a DNA locus and disease status; white bars represent concordance; lines represent unin-
formative genotype. The 3-cM interval containing the Bjornstad syndrome gene is shown. The locations of loci D2S2382, D2S164, D2S2210,
D2S1371, D2S173, D2S434, D2S2179, D2S163, D2S120, and D2S424 are taken from the chromosome 2 gene map. The distances between
these loci are not drawn to scale.
involves both sensorineural hearing loss and pili torti,
individual IV-5, who had hearing loss but normal hair,
was considered as having an unknown clinical status for
the purposes of LOD score calculations.
A genomewide search was performed using polymor-
phic loci. Evidence of linkage was initially detected be-
tween the Bjornstad syndrome gene and D2S434 (LOD
score  4.98; v  0). Linkage between the disease gene
and other chromosome 2q loci was then analyzed. Two-
point LOD scores obtained with 16 polymorphic loci
are shown in table 1. On the basis of linkage analyses
with the chromosome 2 anchor locus, D2S434, the
Bjornstad disease gene was localized to chromosome
2q34-36.
To refine further the location of the disease locus, hap-
lotypes of three individuals who exhibited recombina-
tion across this region were studied (fig. 4). The geno-
types of individuals III-4, IV-1, and IV-3 defined
recombination events and indicated that the disease lo-
cus resided in the 3-cM interval between D2S1371 and
D2S163.
Discussion
We report that the recessive gene mutation responsible
for Bjornstad syndrome in one large kindred maps to
chromosome 2q34-36. All affected individuals with both
pili torti and sensorineural hearing loss were homozy-
gous for alleles between D2S1371 and D2S163. This
interval excludes the nearby PAX3 gene, which is mu-
tated in disorders (Waardenburg syndrome and crani-
ofacial-deafness-hand syndrome) that share some clini-
cal features with Bjornstad syndrome (Tassabehji et al.
1992; Asher et al. 1996).
Clinical analyses of seven heterozygous disease gene
carriers exhibited neither hearing nor hair abnormalities,
but one individual carried the disease haplotype and had
profound prelingual hearing loss. However, his hair tex-
ture, strength, and morphology were normal. Although
his hearing loss might be accounted for by the disease
allele, we suspect that another etiology caused his deaf-
ness. Evaluations of other Bjornstad syndrome families
should help to determine whether Bjornstad syndrome
gene mutations cause other hearing defects.
Hair consists of 50–100 proteins (Rogers and Powell
1993), of which keratins and intermediate fila-
ment–associated proteins (IFAP) predominate (Emonet
et al. 1997). Transgenic mice overexpressing IFAP gene
products have brittle, easily fractured hair (Rogers and
Powell 1993), a finding that further supports the model
that abnormalities in these proteins can alter hair struc-
ture. Defects in keratins, IFAP, or the enzymes involved
in posttranslational modification of these molecules
might be expected to cause the ultrastructural defects of
hair in Bjornstad syndrome.
Sensorineural deafness and pili torti in Bjornstad syn-
drome could be independent phenotypes that result from
the coinheritance of closely linked gene defects. Al-
though our studies do not exclude the possibility of a
contiguous gene syndrome, the recognized immuno-
reactivity of cytokeratins and other IFAPs in the cochlea
(Anniko et al. 1990; Bauwens et al. 1991) makes it ap-
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pealing to consider a single-gene defect that accounts for
both phenotypes. Genes encoding the major structural
components of hair (cytokeratins and IFAPs) therefore
appear to be particularly good candidates for mutations
that account for the distinct manifestations of this
disorder.
At present, only villin encoded on chromosome 2q35
(Rousseau-Merck et al. 1988), colocalizes to the disease
gene interval defined in this study (Schuler et al. 1996).
Although this actin-binding protein is widely expressed
in microvilli (Hofer and Drenckhahn 1996), villin has
not been found in the specialized microvilli, known as
“stereocilia,” of the inner ear (Flock et al. 1982; Alberts
et al. 1994). We therefore anticipate that ongoing anal-
yses of the D2S1371 and D2S163 interval will lead to
the identification of a gene that has a critical role in the
structure of scalp hair and inner-ear cells.
Acknowledgments
J.F.L.N. was sponsored by a scholarship from Coordenacao
de Aperfeicoamento de Pessoal de Nivel Superior, Brazil. This
work was supported in part by grants from the Howard
Hughes Medical Institute to C.E.S. and J.G.S.
References
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD
(1994) Molecular biology of the cell, 3d ed. Garland, New
York
Anniko M, Arnold W, Thornell LE, Virtanen I, Ramaekers FC,
Pfaltz CR (1990) Regional variations in the expression of
cytokeratin proteins in the adult human cochlea. Eur Arch
Otorhinolaryngol 247:182–188
Asher JH Jr, Sommer A, Morell R, Friedman TB (1996) Mis-
sense mutation in the paired domain of PAX3 causes cran-
iofacial-deafness-hand syndrome. Hum Mutat 7:30–35
Bauwens LJ, Veldman JE, Bouman H, Ramaekers FC, Huizing
EH (1991) Expression of intermediate filament proteins in
the adult human cochlea. Ann Otol Rhino Laryngol 100:
211–218
Birnbaum PS, Baden HP (1987) Heritable disorders of the hair.
Dermatol Clin 5:137–153
Bjornstad RT (1965) Pili torti and sensory-neural loss of hear-
ing. Paper presented at the 17th Combined Scandavian Der-
matological Association Meeting, Copenhagen, Denmark,
May 27–29
Cremers CW, Geerts SJ (1979) Sensorineural hearing loss and
pili torti. Ann Otol 88:100–104
Emonet N, Michaille JJ, Dhouailly D (1997) Isolation and
characterization of genomic clones of human sequences pre-
sumably coding for hair cysteine-rich proteins. J Dermatol
Sci 14:1–11
Flock A, Bretscher A, Weber K (1982) Immunohistochemical
localization of several cytoskeletal proteins in inner ear sen-
sory and supporting cells. Hear Res 7:75–89
Gorlin RJ, Toriello HV, Cohen MM (eds) (1995) Hereditary
hearing loss and its syndromes, 2d ed. Oxford University
Press, Oxford
Hofer D, Drenckhahn D (1996) Cytoskeletal differences be-
tween stereocilia of the human sperm passageway and mi-
crovilli/stereocilia in other locations. Anat Rec 245:57–64
Hook EB (1977) Exclusion of chromosomal mosaicism: tables
of 90%, 95%, and 99% confidence limits and comments
on use. Am J Hum Genet 29:94–97
Kurwa AR, Abdel-Aziz AH (1973) Pili torti—congenital and
acquired. Acta Derm Venereol (Stockh) 53:385–392
Marazita ML, Ploughman LM, Rawlings B, Remington E, Ar-
nos KS, Nance WE (1993) Genetic epidemiological studies
of early-onset deafness in the US school-age population. Am
J Med Genet 46:486–491
Morton NE (1991) Genetic epidemiology of hearing impair-
ment. Ann NY Acad Sci 630:16–31
Munro DD (1971) Disorders of the hair. In: Fitzpatrick TB,
Arndt KA, Clark WH, Eisen AZ, VanScott EJ, Vaughan JH
(eds) Dermatology in general medicine. McGraw-Hill, New
York, pp 395–418
Petit A, Dontenwille MM, Bardon CB, Civatte J (1993) Pili
torti with congenital deafness (Bjornstad’s syndrome): report
of three cases in one family, suggesting autosomal dominant
transmission. Clin Exp Dermatol 18:94–95
Petit C (1996) Genes responsible for human hereditary deaf-
ness: symphony of a thousand. Nat Genet 14:385–391
ReardonW (1992) Genetic deafness. J Med Genet 29:521–526
Reed WB, Stone VM, Boder E, Ziprkowski L (1967) Hered-
itary syndromes with auditory and dermatological manifes-
tations. Arch Dermatol 95:456–461
Robinson GC, Johnston MM (1967) Pili torti and sensory
neural hearing loss. J Pediatr 70:621–623
Rogers GE, Powell BC (1993) Organization and expression of
hair follicle genes. J Invest Dermatol 101 Suppl:50S–55S
Ronchese F (1932) Twisted hairs (pili torti). Archives of Der-
matology and Syphilology 26:98–109
Rousseau-Merck MF, Simon-Chazottes D, Arpin M, Pringault
E, Louvard D, Guenet JL, Berger R (1988) Localization of
the villin gene on human chromosome 2q35-q36 and on
mouse chromosome 1. Hum Genet 78:130–133
Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G,
Rice K, White RE, et al (1996) A gene map of the human
genome. Science 274:540–546
Scott MJ, Bronson DM, Esterly NB (1983) Bjornstad syn-
drome and pili torti. Pediatr Dermatol 1:45–50
Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP,
Seidman JG, Seidman CE (1990) A molecular basis for fa-
milial hypertrophic cardiomyopathy: an a/ß cardiac myosin
heavy chain hybrid gene. Cell 62:991–998
Tassabehji M, Read AP, Newton VE, Harris R, Balling R, Guss
P, Strachan T (1992) Waardenburg’s syndrome patients have
mutations in the human homologue of the PAX3 paired box
gene. Nature 355:635–636
Van Camp G, Smith RJH (1998) Hereditary hearing loss ho-
mepage. http://dnalab-www.uia.ac.be/dnalab/hhh
Voigtlander V (1979) Pili torti with deafness (Bjornstad syn-
drome): report of a family. Dermatologica 159:50–54
